Hospitalized Patients With IBD Have Increased Risk of Venous Thromboembolism Post-Discharge

Kenneth R. McQuaid, MD, FASGE reviewing McCurdy JD, et al. Aliment Pharmacol Ther 2019 June.

Hospitalized patients with IBD have a threefold increased risk of venous thromboembolism (VTE), for which current treatment guidelines recommend routine pharmacologic prophylaxis. Recent studies suggest that risk of VTE persists in the early post-discharge period; however, routine extended prophylaxis is not recommended. The aims of the current study were to assess the incidence and risk factors for post-discharge VTE and create a risk stratification tool to guide prophylaxis. At a large, tertiary hospital, the authors retrospectively reviewed the hospital records of 2161 IBD patients and determined the incidence of major VTE within 6 months post-discharge.   

During hospitalization, anticoagulation was administered to 70.6% (1525/2161; 4.5% therapeutic; 66.1% prophylaxis). Post-discharge, 4.4% (95/2161) received extended prophylaxis. During 6-month post-discharge follow-up, 48 symptomatic VTE events occurred (2.2%; median time to VTE of 37 days; range 3-182). On multivariate analysis, risk of post-discharge VTE was associated with age >45 years (OR 3.76; CI: 1.80-7.89) and need for multiple admissions (OR 2.42; CI: 1.23-4.66). Interestingly, need for corticosteroids and intestinal surgery were not associated with increased VTE risk. A prediction model was developed that included patient age, length of stay, ICU admission, need for readmission, and need for central venous line. Using this model, a high-risk group (8.3%; 179/2161) was identified that had an 8.4% risk (15/179) of post-discharge VTE compared with a low-risk group with only a 0.7% risk (7/1028).

Clinicians need to be aware that a subset of hospitalized IBD patients are at increased risk of post-discharge VTE, especially those with multiple admissions or age >45 years. Further work is needed to identify the risk factors for post-discharge VTE and to validate clinical decision tools that will optimize appropriate application of extended prophylaxis.

Kenneth R. McQuaid, MD, FASGE
Bio and Disclosures

Back to Journal Scan

McCurdy JD, Israel A, Hasan M, et al. A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2019;49:1493-1501. (